Literature DB >> 23150668

Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis.

Yang Yang1, Chenji Wang, Pingzhao Zhang, Kun Gao, Dejie Wang, Hongxiu Yu, Ting Zhang, Sirui Jiang, Saiyin Hexige, Zehui Hong, Akira Yasui, Jun O Liu, Haojie Huang, Long Yu.   

Abstract

Polycomb group protein PHF1 is well known as a component of a novel EED-EZH2·Polycomb repressive complex 2 complex and plays important roles in H3K27 methylation and Hox gene silencing. PHF1 is also involved in the response to DNA double-strand breaks in human cells, promotes nonhomologous end-joining processes through interaction with Ku70/Ku80. Here, we identified another function of PHF1 as a potential p53 pathway activator in a pathway screen using luminescence reporter assay. Subsequent studies showed PHF1 directly interacts with p53 proteins both in vivo and in vitro and co-localized in nucleus. PHF1 binds to the C-terminal regulatory domain of p53. Overexpression of PHF1 elevated p53 protein level and prolonged its turnover. Knockdown of PHF1 reduced p53 protein level and its target gene expression both in normal state and DNA damage response. Mechanically, PHF1 protects p53 proteins from MDM2-mediated ubiquitination and degradation. Furthermore, we showed that PHF1 regulates cell growth arrest and etoposide-induced apoptosis in a p53-dependent manner. Finally, PHF1 expression was significantly down-regulated in human breast cancer samples. Taken together, we establish PHF1 as a novel positive regulator of the p53 pathway. These data shed light on the potential roles of PHF1 in tumorigenesis and/or tumor progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23150668      PMCID: PMC3537050          DOI: 10.1074/jbc.M111.338996

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

2.  Frequency of known gene rearrangements in endometrial stromal tumors.

Authors:  Sarah Chiang; Rola Ali; Nataliya Melnyk; Jessica N McAlpine; David G Huntsman; C Blake Gilks; Cheng-Han Lee; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

Review 3.  Polycomb silencing mechanisms and the management of genomic programmes.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

Review 4.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

5.  Polycomblike PHD fingers mediate conserved interaction with enhancer of zeste protein.

Authors:  S O'Connell; L Wang; S Robert; C A Jones; R Saint; R S Jones
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

Review 6.  The INK4a/ARF network in tumour suppression.

Authors:  C J Sherr
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

7.  Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.

Authors:  Kavitha Sarma; Raphael Margueron; Alexey Ivanov; Vincenzo Pirrotta; Danny Reinberg
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

Review 8.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

9.  An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera.

Authors:  Ioannis Panagopoulos; Fredrik Mertens; Constance A Griffin
Journal:  Cancer Genet Cytogenet       Date:  2008-09

10.  A polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell.

Authors:  Zehui Hong; Jie Jiang; Li Lan; Satoshi Nakajima; Shin-ichiro Kanno; Haruhiko Koseki; Akira Yasui
Journal:  Nucleic Acids Res       Date:  2008-04-01       Impact factor: 16.971

View more
  18 in total

Review 1.  Structure of the PRC2 complex and application to drug discovery.

Authors:  Yi Shi; Xiao-Xi Wang; You-Wen Zhuang; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-04-17       Impact factor: 6.150

Review 2.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

Review 3.  Polycomb group proteins and MYC: the cancer connection.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2013-07-30       Impact factor: 9.261

Review 4.  Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.

Authors:  Brian R Rood; Dominique Leprince
Journal:  Expert Opin Ther Targets       Date:  2013-04-09       Impact factor: 6.902

5.  PHF1 is required for chromosome alignment and asymmetric division during mouse meiotic oocyte maturation.

Authors:  Yi Qu; Yang Wang; Jie Qiao
Journal:  Cell Cycle       Date:  2018-11-11       Impact factor: 4.534

6.  Resveratrol reduced the detrimental effects of malondialdehyde on human endothelial cells.

Authors:  Mehdi Hassanpour; Çıgır Biray Avci; Reza Rahbarghazi; Aysa Rezabakhsh; Alireza Nourazarian; Elahe Nabat; Farzaneh Fathi; Majid Khaksar
Journal:  J Cardiovasc Thorac Res       Date:  2021-04-24

7.  Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.

Authors:  T Ozaki; D Wu; H Sugimoto; H Nagase; A Nakagawara
Journal:  Cell Death Dis       Date:  2013-04-25       Impact factor: 8.469

8.  Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?

Authors:  Whitney L Do; Karen Conneely; Sheryl Gabram-Mendola; Uma Krishnamurti; Olivia D'Angelo; Jasmine Miller-Kleinhenz; Keerthi Gogineni; Mylin Torres; Lauren E McCullough
Journal:  Breast Cancer Res Treat       Date:  2020-03-31       Impact factor: 4.624

9.  A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence.

Authors:  Gerard L Brien; Evan Healy; Emilia Jerman; Eric Conway; Elisa Fadda; Darragh O'Donovan; Andrei V Krivtsov; Alan M Rice; Conor J Kearney; Andrew Flaus; Simon S McDade; Seamus J Martin; Aoife McLysaght; David J O'Connell; Scott A Armstrong; Adrian P Bracken
Journal:  Genes Dev       Date:  2015-10-22       Impact factor: 11.361

10.  p53 Suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome.

Authors:  Cinzia Caprio; Antonio Baldini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.